Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2049-2053

  Fan, Lie Ying ^a   Zong, Ming ^a   Wang, Qiang ^b   Yang, Lin ^a   Sun, Li Shan ^a   Ye, Qin ^a   Ding, Yuan Yuan ^a   Ma, Jian Wei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti cyclic citrullinated peptide antibodies; Diagnosis; Glucose 6 phosphate isomerase; Immune complexes; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLUCOSE 6 PHOSPHATE ISOMERASE; MESSENGER RNA; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; COMPLEMENT C1Q; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; SYNOVIAL FLUID; YOUNG ADULT;

EID: 77957754228     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.043     Document Type: Article

References (30)

1. van Boekel M.A., Vossenaar E.R., van den Hoogen F.H., van Venrooij W.J. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002, 4:87-93.
2. Steiner G., Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 2002, Suppl 2:S1-S5.
3. Bizzaro N., Mazzanti G., Tonutti E., Villalta D., Tozzoli R. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001, 47:1089-1093.
4. Irigoyen P., Lee A.T., Wener M.H., et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005, 52:3813-3818.
5. Maccioni M., Zeder-Lutz G., Huang H., et al. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002, 195:1071-1077.
6. Bockermann R., Schubert D., Kamradt T., Holmdahl R. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther 2005, 7:R1316-R1324.
7. McMorris F.A., Chen T.R., Ricciuti F., Tischfield J., Creagan R., Ruddle F. Chromosome assignments in man of the genes for two hexosephosphate isomerases. Science 1973, 179:1129-1131.
8. Walker J.I., Morgan M.J., Faik P. Structure and organization of the human glucose phosphate isomerase gene (GPI). Genomics 1995, 29:261-265.
9. Xu W., Lee P., Beutler E. Human glucose phosphate isomerase: exon mapping and gene structure. Genomics 1995, 29:732-739.
10. Watanabe H., Takehana K., Date M., Shinozaki T., Raz A. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res 1996, 56:2960-2963.
11. Xu W., Seiter K., Feldman E., Ahmed T., Chiao J.W. The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood 1996, 87:4502-4506.
12. Gurney M.E., Heinrich S.P., Lee M.R., Yin H.S. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 1986, 234:566-574.
13. Cao M.J., Osatomi K., Matsuda R., Ohkubo M., Hara K., Ishihara T. Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croaker (Argyrosomus argentatus). Biochem Biophys Res Commun 2000, 272:485-489.
14. Schaller M., Burton D.R., Ditzel H.J. Autoantibodies to G6PI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol 2001, 2:746-753.
15. Schaller M., Stohl W., Tan S.M., Benoit V.M., Hilbert D.M., Ditzel H.J. Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis 2005, 64:743-749.
16. Schaller M., Stohl W., Benoit V., Tan S.M., Johansen L., Ditzel H.J. Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochem Biophys Res Commun 2006, 349:838-845.
17. Funasaka T., Yanagawa T., Hogan V., Raz A. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J 2005, 19:1422-1430.
18. Niizeki H., Kobayashi M., Horiuchi I., et al. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer 2002, 86:1914-1919.
19. Naughton D.P. Hypoxia-induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis. Med Hypotheses 2003, 60:332-334.
20. Vincent C., Nogueira L., Clavel C., Sebbag M., Serre G. Autoantibodies to citrullinated proteins: ACPA. Autoimmunity 2005, 38:17-24.
21. Schellekens G.A., Visser H., de Jong B.A., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
22. Vallbracht I., Rieber J., Oppermann M., Forger F., Siebert U., Helmke K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004, 63:1079-1084.
23. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
24. Nielen M.M., van Schaardenburg D., Reesink H.W., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
25. Lindqvist E., Eberhardt K., Bendtzen K., Heinegard D., Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005, 64:196-201.
26. Meyer O., Labarre C., Dougados M., et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003, 62:120-126.
27. Kastbom A., Strandberg G., Lindroos A., Skogh T. Anti-CCP antibody test predicts the disease course during 3years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004, 63:1085-1089.
28. Mikuls T.R., O'Dell J.R., Stoner J.A., et al. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis Rheum 2004, 50:3776-3782.
29. Vossenaar E.R., Després N., Lapointe E., et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004, 6:R142-R150.
30. Mathsson L., Mullazehi M., Wick M.C., et al. Antibodies against citrullinated vimentin in rheumatoid arthritis higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 2008, 58:36-45.